231 related articles for article (PubMed ID: 33345573)
1. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
Serrano PE; Gu CS; Moulton CA; Gallinger S
Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573
[TBL] [Abstract][Full Text] [Related]
2. Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
Serrano PE; Gu CS; Moulton CA; Husien M; Jalink D; Martel G; Tsang ME; Hallet J; McAlister V; Gallinger S; Levine M
J Surg Oncol; 2020 May; 121(6):1001-1006. PubMed ID: 32034769
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE
Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
5. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients With Indeterminate Extrahepatic Disease on 18FDG-PET Scan Before Liver Resection for Metastatic Colorectal Cancer.
Wong GYM; Kumar R; Beeke C; Ullah S; Chen J; Karapetis C; Price T; Padbury R
Ann Surg; 2018 May; 267(5):929-935. PubMed ID: 28169837
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
[TBL] [Abstract][Full Text] [Related]
8. Does
Jonsson J; Hemmingsson O; Strengbom R; Axelsson J; Riklund K; Nyström H
Scand J Surg; 2022; 111(1):14574969221083144. PubMed ID: 35348393
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Metser U; Halankar J; Langer D; Mohan R; Hussey D; Hadas M; Tamir S
Ann Nucl Med; 2017 Feb; 31(2):153-162. PubMed ID: 27848159
[TBL] [Abstract][Full Text] [Related]
11. Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.
Serrano PE; Gafni A; Gu CS; Gulenchyn KY; Julian JA; Law C; Hendler AL; Moulton CA; Gallinger S; Levine MN
J Oncol Pract; 2016 Jul; 12(7):e765-74. PubMed ID: 27328792
[TBL] [Abstract][Full Text] [Related]
12. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
13. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of
Grut H; Dueland S; Line PD; Revheim ME
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):218-225. PubMed ID: 29026950
[TBL] [Abstract][Full Text] [Related]
15. PET-CT as a predictor of outcome in resectable colorectal liver metastases.
Jones C; Badger SA; Stevenson M; Diamond T; McKie LD; Taylor MA; Wilson RH; Lynch TB
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):466-72. PubMed ID: 24445726
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.
Viganò L; Langella S; Ferrero A; Russolillo N; Sperti E; Capussotti L
Ann Surg Oncol; 2013 Mar; 20(3):938-45. PubMed ID: 23010733
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.
Huang YT; Park J; Chong S; Hugh TJ; Ng WL; Lin M
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e262-e270. PubMed ID: 27451967
[TBL] [Abstract][Full Text] [Related]
18. Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
Grut H; Stern NM; Dueland S; Labori KJ; Dormagen JB; Schulz A
Nucl Med Commun; 2020 Sep; 41(9):916-923. PubMed ID: 32796480
[TBL] [Abstract][Full Text] [Related]
19. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Viganò L; Lopci E; Costa G; Rodari M; Poretti D; Pedicini V; Solbiati L; Chiti A; Torzilli G
Ann Surg Oncol; 2017 Apr; 24(4):1029-1036. PubMed ID: 27807727
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
